Ivo Roelants

KBC Insurance NV provides risk management and non-life insurance services. The firm offers liability insurance brokerage and industrial accidents, car & fleet, asset protection and debtor management services. The company is headquartered in Brussels, Belgium.

Vlaamse Instelling Voor Technologisch Onderzoek NV provides customer research services. The company provides its services to the energy suppliers, appliance builders, end users and government sectors. The company was founded in 1991 and is headquartered in Mol, Belgium.

Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium.

Axilius NV manufactures transformers and lathes. The company is headquartered in Leuven, Belgium.

Leuven Air Bearings NV develops and produces air bearing solutions. It provides services to industrial automation, process control, compressor and power generation industries. The company was founded by Farid Al-Bender in 2006 and is headquartered in Leuven, Belgium.

it4ip SA engages in the development and manufacture of porous templates and membranes. Its applications are used for direct observation and rapid quantification of biological cells or µ-organisms for cancer diagnosis, diffusion control in biosensors, particle capture tests, rare event recovery, and fuel cells. The company was founded by Roger Marcel Henri Legras, Laurent Marie Ghislain Jonckheere, Etienne Robert Christian Ferain, Marie Rose Laure Germaine Delleur, Yves-Jacques Schneider, and Henri Hanot in 2006 and is headquartered in Louvain-la-Neuve, Belgium.

Biotech Coaching SA (Biotech Coaching) is a venture capital firm founded 2006. The firm is headquartered in Liege, Belgium.

Biotreatment SA develops processes for biological treatment of environment and specifically the treatment of hydrocarbons, organic waste and waste management. It offers analysis of organic waste, selection of micro-organisms in natural habitats, production of micro-organisms, and analysis of polluted environments. The company is headquartered in Liege, Belgium.

Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Société de Développement pour la Region de Bruxelles-Capitale is a construction company based in Brussels, Belgium. and has subsidiaries in Belgium. Société de Développement pour la Region de Bruxelles-Capitale engages in the construction of residential buildings. The Belgian company was founded in 1974. Thomas Ryckalts has been the CEO of the private company since 2020.

Technopolis NV provides science and technology services in Flanders. It operates a platform for science and technology in Flanders and has evolved from a non-profit organization, the Flanders Technology International. The company was founded on September 5, 1997 and is headquartered in Mechelen, Belgium.

SD Worx Sociaal Secretariaat VZW engages in the provision of payroll, human resources and legal solutions. It offers staffing, compensation and benefits, training courses, consulting, and research services. The company was founded on October 22, 1946 and is headquartered in Antwerp, Belgium.

Federation of Enterprises in Belgium ASBL/VZW fka Federation des Entreprises de Belgique is the only multi-sector employers' organization representing companies in all three regions of Belgium. Its members, Belgium's leading sectoral federations, represent companies in key industrial and service sectors. The company was founded in 1973 and is headquartered in Brussels, Belgium.

Willemen Groep NV provides civil engineering and construction services. It offers residential, civil engineering, road, industrial, renovation, public private partnerships, DBFM projects, and commercial construction services. The company was founded in June 1999 by Pierre-François Van Poppel and is headquartered in Mechelen, Belgium.

Guberna vzw is an organization that aims to promote good governance in all types of organizations. The private company is based in Brussels, Belgium. The Belgian company believes that good governance leads to better organizations, which in turn contribute to a better world. To achieve this mission, Guberna focuses on three strategic pillars\: knowledge development, lifelong learning, and networking. Good governance involves boards, control, accountability, supervision, and control, and is a means to realize the organizational strategy.

Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium.

AGC Glass Europe SA manufactures and distributes flat glass. It offers flat and floats glass technology. The company was founded in 2002 and is headquartered in Louvain-la-Neuve, Belgium.

Endo Tools Therapeutics SA manufactures medical devices. It focuses on the development of devices providing new means of therapeutic interventions for gastroenterologists. The company was founded by Jacques Deviere, Alain Delchambre and Nicolas Cauche in 2003 and is headquartered in Gosselies, Belgium.

Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.

Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium.

Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.

Centre de Ressources Technologiques en Chimie is a research and Belgian development company that provides analytical and technological services. The non-profit company is based in Seneffe, Belgium and was founded in 1999.

Willemen Infra is a construction group that offers a wide range of building activities, including civil projects, industrial construction, residential and utility projects, and road and airport construction. The private company is based in Ghent, Belgium. The Belgian company follows the lean philosophy to eliminate waste and improve project quality and customer value. Willemen Real Estate, a subsidiary of the company, develops and executes energy-efficient and high-quality apartment buildings, PPS and mixed-use projects, student and service flats, and other residential projects across Belgium. The company's customer-oriented approach and collaboration with real estate agents are the keys to its success. The company was founded in 1949, and Tom Willemen has been the CEO of the company since 2021.

Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation.